chr6-129366182-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000426.4(LAMA2):c.4718-37G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000579 in 1,609,702 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0033   (  2   hom.,  cov: 32) 
 Exomes 𝑓:  0.00030   (  2   hom.  ) 
Consequence
 LAMA2
NM_000426.4 intron
NM_000426.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.22  
Publications
0 publications found 
Genes affected
 LAMA2  (HGNC:6482):  (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008] 
LAMA2 Gene-Disease associations (from GenCC):
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62). 
BP6
Variant 6-129366182-G-A is Benign according to our data. Variant chr6-129366182-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 256071.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0033 (500/151594) while in subpopulation AFR AF = 0.0116 (479/41326). AF 95% confidence interval is 0.0107. There are 2 homozygotes in GnomAd4. There are 250 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00329  AC: 499AN: 151476Hom.:  2  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
499
AN: 
151476
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000889  AC: 223AN: 250776 AF XY:  0.000620   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
223
AN: 
250776
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000296  AC: 432AN: 1458108Hom.:  2  Cov.: 30 AF XY:  0.000245  AC XY: 178AN XY: 725618 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
432
AN: 
1458108
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
178
AN XY: 
725618
show subpopulations 
African (AFR) 
 AF: 
AC: 
351
AN: 
33410
American (AMR) 
 AF: 
AC: 
25
AN: 
44720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26104
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39656
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86164
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53196
Middle Eastern (MID) 
 AF: 
AC: 
2
AN: 
5758
European-Non Finnish (NFE) 
 AF: 
AC: 
6
AN: 
1108854
Other (OTH) 
 AF: 
AC: 
47
AN: 
60246
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.479 
Heterozygous variant carriers
 0 
 22 
 44 
 65 
 87 
 109 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00330  AC: 500AN: 151594Hom.:  2  Cov.: 32 AF XY:  0.00338  AC XY: 250AN XY: 74018 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
500
AN: 
151594
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
250
AN XY: 
74018
show subpopulations 
African (AFR) 
 AF: 
AC: 
479
AN: 
41326
American (AMR) 
 AF: 
AC: 
17
AN: 
15172
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5118
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4792
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10466
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
67940
Other (OTH) 
 AF: 
AC: 
3
AN: 
2102
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 24 
 48 
 71 
 95 
 119 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1
AN: 
3478
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Jul 15, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.